Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
JAMA|April 5, 2012
Oral fluoroquinolones and the risk of retinal detachmentMahyar Etminan, Farzin Forooghian, James M Brophy, et al.JAMA Dermatology|February 22, 2013
Isotretinoin and risk for inflammatory bowel disease: a nested case-control study and meta-analysis of published and unpublished dataMahyar Etminan, Steven T Bird, Joseph A Delaney, et al.The Journal of Urology|May 14, 2013
Male breast cancer and 5α-reductase inhibitors finasteride and dutasterideSteven T Bird, James M Brophy, Abraham G Hartzema, et al.Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|January 15, 2013
Polycystic ovary syndrome and combined oral contraceptive use: a comparison of clinical practice in the United States to treatment guidelinesSteven T Bird, Abraham G Hartzema, Mahyar Etminan, et al.CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 5, 2013
Risk of acute kidney injury associated with the use of fluoroquinolonesSteven T Bird, Mahyar Etminan, James M Brophy, et al.CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|December 5, 2012
Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysisSteven T Bird, Abraham G Hartzema, James M Brophy, et al.Pharmacoepidemiology and Drug Safety|December 29, 2016
A systematic review of pregnancy exposure registries: examination of protocol-specified pregnancy outcomes, target sample size, and comparator selectionKate Gelperin, Hoda Hammad, Kira Leishear, et al.Journal of the American Heart Association|June 12, 2013
Antihypertensive drug class interactions and risk for incident diabetes: a nested case-control studyRhonda M Cooper--DeHoff, Steven T Bird, Gregory A Nichols, et al.Current Drug Safety|June 6, 2012
Irritable bowel syndrome and drospirenone-containing oral contraceptives; a comparative-safety studySteven T Bird, Wei Liu, James M Brophy, et al.BMC Clinical Pharmacology|January 3, 2012
The association between drospirenone and hyperkalemia: a comparative-safety studySteven T Bird, Salvatore R Pepe, Mahyar Etminan, et al.Pageof 3